Gayle Deflin is of Amphastar Pharmaceuticals, Inc.. Currently has a direct ownership of 5,792 shares of AMPH, which is worth approximately $226,698. The most recent transaction as insider was on Jun 03, 2024, when has been sold 3,076 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.79K
0% 3M change
113.25% 12M change
Total Value Held $226,698

Gayle Deflin Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 03 2024
BUY
Grant, award, or other acquisition
-
3,076 Added 34.69%
5,792 Common Stock
Nov 14 2023
SELL
Open market or private sale
$230,838 $55.45 p/Share
4,163 Reduced 60.52%
2,716 Common Stock
Jun 05 2023
BUY
Grant, award, or other acquisition
-
2,716 Added 28.31%
6,879 Common Stock
May 18 2023
SELL
Open market or private sale
$198,881 $44.01 p/Share
4,519 Reduced 52.05%
4,163 Common Stock
May 15 2023
SELL
Open market or private sale
$64,725 $43.15 p/Share
1,500 Reduced 14.73%
8,682 Common Stock
Jun 10 2022
BUY
Grant, award, or other acquisition
-
4,163 Added 29.02%
10,182 Common Stock
Jun 07 2021
BUY
Grant, award, or other acquisition
-
6,019 Added 50.0%
6,019 Common Stock
GD

Gayle Deflin

Rancho Cucamonga, CA

Track Institutional and Insider Activities on AMPH

Follow Amphastar Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AMPH shares.

Notify only if

Insider Trading

Get notified when an Amphastar Pharmaceuticals, Inc. insider buys or sells AMPH shares.

Notify only if

News

Receive news related to Amphastar Pharmaceuticals, Inc.

Track Activities on AMPH